Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2007 Annual Meeting | Mild Cognitive Impairment: Implications for Clinicians

Sunday 04/29/07
06:00 PM - 09:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Dinner Seminar
Ronald C. Petersen, MD, PhD, FÂ鶹´«Ã½Ó³»­
Participants should be familiar with the diagnostic criteria for MCI, the underlying neurochemistry and pathology of the disease, currently available treatments, and treatments in development.
No CME available
Medical Knowledge
Advanced
Practitioner, Fellow, Academician, Resident
Event Timeline
05:45 PM - 09:00 PM Dinner
06:30 PM - 06:50 PM Overview of MCI
Ronald C. Petersen, MD, PhD, FÂ鶹´«Ã½Ó³»­
06:50 PM - 07:10 PM Neurochemistry, Neuropathology, and Imaging in MCI
Steven T. DeKosky, MD, FÂ鶹´«Ã½Ó³»­
07:10 PM - 07:30 PM Treatment of MCI
Martin R. Farlow, MD, FÂ鶹´«Ã½Ó³»­
07:30 PM - 09:00 PM Case Presentations in MCI
Faculty Disclosures
Ronald C. Petersen, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Steven T. DeKosky, MD, FÂ鶹´«Ã½Ó³»­ Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. DeKosky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail Pharamceuticls. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex, Inc. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up-To-Date. Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics .
Martin R. Farlow, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file